Clinical Trials Directory

Trials / Unknown

UnknownNCT05785650

Trigger Points of Supraspinatus Muscle: Osteopaths' Palpation Reproductibility and Ultrasound Translation

Status
Unknown
Phase
Study type
Observational
Enrollment
61 (estimated)
Sponsor
Institut des Hautes Etudes Osteopathiques de Nantes · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Trigger points (TP) are described as "hard, palpable nodules located within the taut bands of skeletal muscle" (Bardoni, 2022). The aim of this study is to evaluate the reproductibility of palpation of TP between osteopaths and to compare this perception to ultrasound measures of echogenicity. Method: A sample of 61 patients will be included in the study. An osteopath will determine the eligibility of the study. The supraclavicular area will be mark every 2 cm to establish a grid for all evaluations. First an osteopath will evaluate with palpation the presence of TP at every box of the grid. A second osteopath will evaluate the same boxes and will be blinded to the result of the first osteopath. At each step of palpation, a pain assessment will be carried out at each box. Then, the ultrasound technician will evaluate the echogeneicity of every box and will be blinded to the prior results. The protocol will be approve by a french ethic committee.

Detailed description

sensitivity and specificity of osteopathic tests will be conducted in comparaison to echograph results (a binary outcomes assessing the presence of an hypoechogenicity). The reproductibility of osteopaths' tests will be be calculated using Cohen's kappa weighted by the distance between the TPs found. Finally, the pain reported by patients on areas with a TP defined by the osteopath, and the pain reported by patients on areas without a TP defined by the osteopath will be compared using a student test.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTosteopathic palpationcomparaison of ultrasound caracteristics of areas with ad without TP

Timeline

Start date
2023-08-30
Primary completion
2024-02-28
Completion
2024-05-31
First posted
2023-03-27
Last updated
2023-07-20

Source: ClinicalTrials.gov record NCT05785650. Inclusion in this directory is not an endorsement.